Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Details)

v3.6.0.2
Segment Reporting (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Jun. 30, 2016
Segment Reporting Information [Line Items]          
Revenues - external customers $ 75 $ 134 $ 210 $ 294  
Revenues - intersegment 0 0 0 0  
Research and development 1,049 704 1,869 1,255  
General and administrative 2,351 1,684 4,820 3,106  
Operating loss (3,325) (2,254) (6,479) (4,067)  
Interest expense (483) 0 (966) 0  
Interest and other income 16 8 41 16  
Consolidated net loss (3,792) (2,246) (7,404) (4,051)  
Total assets 44,188 9,416 44,188 9,416 $ 51,600
Fixed assets, net 25,453 14 25,453 14 25,574
Intangible assets, net 1,960 2,201 1,960 2,201 $ 2,092
Depreciation expense 326 1 650 2  
Amortization of intangible assets 88 91 176 182  
Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Revenues - external customers 0   49    
Revenues - intersegment 407   589    
Research and development 447   768    
General and administrative 1,363   2,634    
Operating loss (1,403)   (2,764)    
Interest expense (483)   (966)    
Interest and other income 7   14    
Consolidated net loss (1,879)   (3,716)    
Total assets 34,333   34,333    
Fixed assets, net 25,446   25,446    
Intangible assets, net 0   0    
Depreciation expense 325   648    
Amortization of intangible assets 0   0    
Intersegment Eliminations [Member]          
Segment Reporting Information [Line Items]          
Revenues - external customers 0 0 0 0  
Revenues - intersegment (667) 0 (1,001) 0  
Research and development (414) 0 (599) 0  
General and administrative (253) 0 (402) 0  
Operating loss 0 0 0 0  
Interest expense 0 0 0 0  
Interest and other income 0 0 0 0  
Consolidated net loss 0 0 0 0  
Total assets (15) 0 (15) 0  
Fixed assets, net 0 0 0 0  
Intangible assets, net 0 0 0 0  
Depreciation expense 0 0 0 0  
Amortization of intangible assets 0 0 0 0  
iBio, Inc. [Member] | Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Revenues - external customers 75 134 161 294  
Revenues - intersegment 260 0 412 0  
Research and development 1,016 690 1,700 1,241  
General and administrative 1,241 1,596 2,588 3,018  
Operating loss (1,922) (2,152) (3,715) (3,965)  
Interest expense 0 0 0 0  
Interest and other income 9 8 27 16  
Consolidated net loss (1,913) (2,144) (3,688) (3,949)  
Total assets 9,870 9,416 9,870 9,416  
Fixed assets, net 7 14 7 14  
Intangible assets, net 1,960 2,201 1,960 2,201  
Depreciation expense 1 1 2 2  
Amortization of intangible assets $ 88 91 $ 176 182  
iBio CMO [Member] | Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Revenues - external customers [1]   0   0  
Revenues - intersegment [1]   0   0  
Research and development [1]   14   14  
General and administrative [1]   88   88  
Operating loss [1]   (102)   (102)  
Interest expense [1]   0   0  
Interest and other income [1]   0   0  
Consolidated net loss [1]   (102)   (102)  
Total assets   0   0  
Fixed assets, net [1]   0   0  
Intangible assets, net [1]   0   0  
Depreciation expense [1]   0   0  
Amortization of intangible assets [1]   $ 0   $ 0  
[1] iBio CMO commenced operations in December 2015